Skip to main content

Colgate-Palmolive vs Kimberly-Clark: Revenue, Profit and Business Model

Colgate-Palmolive had $20.4B of annual revenue in FY2025. Kimberly-Clark had $16.4B of annual revenue in FY2025 and $2B of net income.

Latest financial snapshot

Colgate-Palmolive

Latest annual revenue
$20.4B (FY2025)
Net income
Unavailable here
Net margin
—
Revenue growth
+3.3% a year, FY2016–FY2025

Kimberly-Clark

Latest annual revenue
$16.4B (FY2025)
Net income
$2B
Net margin
12.3%
Revenue growth
-1.1% a year, FY2016–FY2025

Financial summary

Colgate-Palmolive

Colgate-Palmolive's revenue is steady rather than fast-growing. Net sales rose from $17.97 billion in 2022 to $20.10 billion in 2024 and $20.38 billion in 2025 (+1.4%, organic +1.4%). 2025 GAAP EPS fell 25% to $2.63 because of goodwill and intangible impairment charges tied to the skin health business (mainly Filorga), while Base Business EPS rose 3% to $3.69. Operating cash flow hit a record $4.2 billion and the company returned $2.9 billion through dividends and buybacks. In Q2 2026 net sales grew 4.9% to $5.361 billion, organic sales rose 2.4% and gross margin expanded 140 basis points to 61.5%. Colgate-Palmolive Company is a dominant multinational consumer products corporation, sustaining a market valuation typically over $70 billion.

Kimberly-Clark

FY2025 net sales from continuing operations were $16.447 billion, down 2.1% from $16.805 billion in 2024, largely reflecting exits such as US private-label diapers and currency. Gross profit was $5.923 billion, operating profit $2.351 billion and net income attributable to Kimberly-Clark $2.021 billion. In Q2 2026 net sales were $4.19 billion (up 0.6%), adjusted gross margin rose 190 basis points to 38.8%, and adjusted EPS attributable to the company was $2.12, while reported net income fell to $345 million from $509 million on deal and restructuring costs. Market value was about $33 billion in late September 2026. Kimberly-Clark Corporation is a colossal American multinational personal care corporation, commanding a market valuation typically over $45 billion.

Revenue and profit by year

Colgate-Palmolive

Colgate-Palmolive revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$20.4B——+1.4%Source
FY2024$20.1B——+3.3%Source
FY2023$19.5B——+8.3%Source
FY2022$18B——+3.1%Source
FY2021$17.4B$2.2B12.4%+5.8%Source
FY2020$16.5B$2.7B16.4%+5.0%Source
FY2019$15.7B$2.4B15.1%+1.0%Source
FY2018$15.5B$2.4B15.4%+0.6%Source
FY2017$15.5B$2B13.1%+1.7%Source
FY2016$15.2B$2.4B16.1%—Source
Full Colgate-Palmolive financials

Kimberly-Clark

Kimberly-Clark revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$16.4B$2B12.3%-2.1%Source
FY2024$16.8B$2.5B15.1%-2.0%Source
FY2023$17.1B$1.8B10.3%-15.0%Source
FY2022$20.2B$1.9B9.6%+3.8%Source
FY2021$19.4B$1.8B9.3%+1.6%Source
FY2020$19.1B$2.4B12.3%+3.7%Source
FY2019$18.4B$2.2B11.7%-0.2%Source
FY2018$18.5B$1.4B7.6%+0.8%Source
FY2017$18.3B$2.3B12.4%+0.8%Source
FY2016$18.2B$2.2B11.9%—Source
Full Kimberly-Clark financials

Where the revenue comes from

Colgate-Palmolive

  • Oral Care

    Largest category

    Toothpaste, toothbrushes, mouthwash, whitening, and professional oral-care products under brands such as Colgate and elmex.

  • Pet Nutrition

    Major growth category

    Hill's Science Diet and Hill's Prescription Diet pet food sold through retail and veterinary channels.

  • Personal Care

    Major category

    Soap, body wash, deodorant, and personal-care brands including Palmolive, Softsoap, Irish Spring, and Sanex.

  • Home Care

    Smaller category

    Dishwashing, household cleaning, and fabric-care products, with brand strength in select global markets.

Kimberly-Clark

  • North America

    Not formally reported

    Huggies, Pull-Ups, Kleenex, Cottonelle, Scott, Viva, Kotex, Depend and Poise sold to US and Canadian retailers, plus the North American professional business.

  • International Personal Care

    Not formally reported

    Diapers, feminine care and adult care outside North America, including Huggies, Kotex and Softex.

  • International Family Care and Professional (discontinued)

    Not formally reported

    International tissue and professional products reported as discontinued operations after being contributed to the Arbex joint venture with Suzano.

Business model and strategy

Colgate-Palmolive

How it makes money

Colgate-Palmolive sells high-frequency, repeat-purchase consumer products. Revenue comes from four categories: Oral Care (Colgate, elmex, meridol, Tom's of Maine, hello), Personal Care (Palmolive, Softsoap, Irish Spring, Protex, Sanex, Speed Stick, EltaMD, PCA Skin, Filorga), Home Care (Ajax, Fabuloso, Palmolive dish liquid, Suavitel) and Pet Nutrition (Hill's Science Diet and Hill's Prescription Diet).

Growth strategy

Colgate-Palmolive's growth plan centers on premium oral care (whitening, sensitivity, gum health and electric brushes), expanding Hill's Science Diet and Prescription Diet, and selective skin health brands such as EltaMD and PCA Skin. Productivity savings fund higher advertising, and the company has exited low-margin private-label pet food to focus Hill's on its own brands.

Competitive advantage

Colgate-Palmolive's advantage is reach plus professional endorsement. Colgate toothpaste held 41.3% global share and manual toothbrushes 32.7% year to date in 2026, built on distribution that reaches small traditional-trade shops across India, Latin America and Africa.

Colgate-Palmolive business model in full

Kimberly-Clark

How it makes money

Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products through retailers, e-commerce and distributors.

Growth strategy

Under its Powering Care strategy, Kimberly-Clark focuses on premium innovation (such as Huggies Skin Essentials and Depend upgrades), productivity savings, exiting low-margin businesses like US private-label diapers, and moving its international tissue business into the Arbex joint venture. It is also building an alternative natural fibers pilot plant in the US Southwest using the drought-tolerant hesperaloe plant.

Competitive advantage

Kimberly-Clark's advantages are category-defining brands (Kleenex is used as a generic word for tissue), large-scale nonwoven and absorbent manufacturing that is expensive to replicate, long retailer relationships, and an innovation pipeline in diapers and adult care. Its productivity program has delivered gross savings that helped lift adjusted gross margin to 38.8% in Q2 2026.

Kimberly-Clark business model in full

Questions about Colgate-Palmolive vs Kimberly-Clark

Which company has higher revenue — Colgate-Palmolive Company or Kimberly-Clark Corporation?

Colgate-Palmolive Company had $20.4B (FY2025), while Kimberly-Clark Corporation had $16.4B (FY2025). By latest annual revenue, Colgate-Palmolive Company is the larger business, with Kimberly-Clark Corporation showing a smaller revenue base.

What is the market cap of Colgate-Palmolive Company vs Kimberly-Clark Corporation?

Colgate-Palmolive Company's market capitalisation stands at $69.0B, while Kimberly-Clark Corporation's is $33.0B. Colgate-Palmolive Company carries the higher market valuation, reflecting investors' expectations of its future earnings power relative to Kimberly-Clark Corporation.

How does revenue per employee compare for Colgate-Palmolive Company and Kimberly-Clark Corporation?

Colgate-Palmolive Company has $607k / employee in revenue per employee, while Kimberly-Clark Corporation has $457k / employee. Headcounts may use different dates, so the ratio alone does not establish which business operates more efficiently.

How do Colgate-Palmolive Company and Kimberly-Clark Corporation make money?

Colgate-Palmolive Company and Kimberly-Clark Corporation generate revenue in fundamentally different ways. Colgate-Palmolive Company: Colgate-Palmolive sells high-frequency, repeat-purchase consumer products. Kimberly-Clark Corporation: Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products through retailers, e-commerce and distributors.

Which company is valued higher relative to revenue — Colgate-Palmolive Company or Kimberly-Clark Corporation?

On a price-to-sales (P/S) basis, Colgate-Palmolive Company trades at 3.4x P/S and Kimberly-Clark Corporation at 2.0x P/S. Colgate-Palmolive Company commands a higher revenue multiple, typically indicating that investors expect faster growth or higher future margins compared to Kimberly-Clark Corporation. A higher multiple is not inherently better — it may also signal that the stock is priced for perfection.

Is Colgate-Palmolive Company bigger than Kimberly-Clark Corporation?

By last reported revenue, Colgate-Palmolive Company ($20.4B (FY2025)) is the larger company compared to Kimberly-Clark Corporation ($16.4B (FY2025)). Revenue scale is one dimension of size — market capitalisation, employee count, and geographic reach are also relevant depending on the context.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Colgate-Palmolive vs Kimberly-Clark overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.